This action might not be possible to undo. Are you sure you want to continue?
Federal Register / Vol. 70, No. 18 / Friday, January 28, 2005 / Notices II. 15 NOTICES OF COMMENCEMENT FROM: 12/01/04 TO 12/14/04—Continued
Case No. P–04–0519 P–04–0611 P–04–0626 P–04–0659 P–04–0683 P–04–0710 P–04–0752 P–04–0793 P–04–0815 P–04–0891 P–93–1704
Received Date 11/30/04 12/07/04 12/08/04 12/14/04 12/06/04 12/06/04 11/30/04 12/06/04 12/06/04 12/01/04 12/13/04
Commencement Notice End Date 11/24/04 11/03/04 11/09/04 11/16/04 11/23/04 11/15/04 11/12/04 11/20/04 11/16/04 11/02/04 11/29/04
Chemical (G) Substituted benzenesulfonic acid substituted pyrazol azo phenyl amino triazin amino substituted phenyl compound (S) (1r,4s)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.01,6]undec-5-ene (G) Substituted phenol, polymer with polyalkylene polyether polyol and epichlorohydrin (G) N-sulfoalkyl-aminocarbonylalkenyl, polymer modified with n,n-dialkylaminocarbonylalkenyl, calcium salt (G) Substituted pyridinecarbonitrile pigment (G) Alkyl methacrylate copolymer (G) Organomodified siloxane and silicone (G) Essential oil (G) Styrene acrylic copolymer (G) Dynacoll 7250, dynacoll 7140 (G) Polyester polyol isocyanate polymer reaction products
List of Subjects Environmental protection, Chemicals, Premanufacturer notices.
Dated: January 13, 2005. Vicki A. Simons, Acting Director, Information Management Division, Office of Pollution Prevention and Toxics. [FR Doc. 05–1637 Filed 1–27–05; 8:45 am]
BILLING CODE 6560–50–S
DEPARTMENT OF HEALTH AND HUMAN SERVICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting.
Name: National Committee on Vital and Health Statistics (NCVHS), Subcommittee on Standards and Security (SSS). Time and Date: February 1st, 2005 9 a.m.– 5 p.m., February 2nd, 2005 9 a.m.–1 p.m. Place: Hubert H. Humphrey Building, 200 Independence Avenue, SW., Room 505A, Washington, DC 20201. Status: Open. Purpose: The Subcommittee will continue to focus on potential e-prescribing standards, including a discussion on the use of RxNorm in the e-prescribing context and an update from the industry on the progress of related workgroups (e.g., codified SIG). The development of a draft recommendation letter to the HHS Secretary will be discussed. Contact Person For More Information: Substantive program information as well as summaries of meetings and a roster of Committee members may be obtained from Maria Friedman, Health Insurance Specialist, Security and Standards Group, Centers for Medicare and Medicaid Services, MS: C5– 24–04, 7500 Security Boulevard, Baltimore, MD 21244–1850, telephone: 410–786–6333 or Marjorie S. Greenberg, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, Room 1100, Presidential Building, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone: (301) 458–4245. Information also is available on the NCVHS home page of the HHS Web site: http:// www.ncvhs.hhs.gov/ where an agenda for the meeting will be posted when available. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (301) 458–4EEO (4336) as soon as possible.
Dated: January 14, 2005. James Scanlon, Acting Deputy Assistant Secretary for Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 05–1619 Filed 1–27–05; 8:45 am]
BILLING CODE 4151–05–M
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention
EXPORT–IMPORT BANK OF THE UNITED STATES Sunshine Act Meeting
Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call (404) 371–5976 or send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to email@example.com. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information
Notice of a partially open meeting of the Board of Directors of the Export-Import Bank of the United States.
TIME AND PLACE:
Thursday, February 3, 2005 at 9:30 a.m. The meeting will be held at Ex-Im Bank in Room 1143, 811 Vermont Avenue, NW., Washington, DC 20571. Ex-Im Bank SubSaharan Africa Advisory Committee for 2005.
OPEN AGENDA ITEM:
The meeting will be open to public participation for Item No. 1 only. For further information, contact: Office of the Secretary, 811 Vermont Avenue, NW., Washington, DC 20571 (Tel. No. (202) 565–3957).
James K. Hess, Senior Vice President and Chief Financial Officer. [FR Doc. 05–1727 Filed 1–26–05; 12:39 pm]
BILLING CODE 6690–01–M
15:43 Jan 27, 2005
Federal Register / Vol. 70, No. 18 / Friday, January 28, 2005 / Notices
on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Requirement for a Special Permit to Import Cynomolgus, African Green, or Rhesus Monkeys into the United States (0920–0263)—Revision—National Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC). A registered importer must request a special permit to import Cynomolgus, African Green, or Rhesus Monkeys. To receive a special permit to import nonhuman primates the importer must submit to the Director of CDC, a written plan which specifies the steps that will be taken to prevent exposure of persons and animals during the entire importation and quarantine process for the arriving nonhuman primates. Under the special permit arrangement, registered importers must submit a plan to CDC for the importation and quarantine if they wish to import the specific monkeys covered. The plan must address disease prevention procedures to be carried out in every step of the chain of custody of such monkeys, from embarkation in the country of origin to release from quarantine. Information such as species, origin and intended use for monkeys, transit information, isolation and quarantine procedures, and procedures for testing of quarantined animals is necessary for CDC to make public health decisions. This information enables CDC to evaluate compliance with the standards and to determine whether the measures being taken to prevent exposure of persons and animals during importation are adequate. Once CDC is assured, through the monitoring of
Number of respondents 5 1 3 12 ........................
shipments (normally no more than 2), that the provisions of a special permit plan are being followed by a new permit holder and that the use of adequate disease control practices is being demonstrated, the special permit is extended to cover the receipt of additional shipments under the same plan for a period of 180 days, and may be renewed upon request. This eliminates the burden on importers to repeatedly report identical information, requiring only that specific shipment itineraries and information on changes to the plan which require approval be submitted. Respondents are commercial or notfor-profit importers of nonhuman primates. The burden represents full submission of information and itinerary/change information respectively. There are no costs to respondents except for their time to complete the requisition process.
Number of responses per respondent 2 3 2 2 Average burden per response (in hours) 30/60 10/60 30/60 10/60 ........................ Total burden hours 5 .5 3 4 12.5
Business (limited permit) ............................................................................... Businesses (extended permit) ....................................................................... Organizations (limited permit) ........................................................................ Organizations (extended permit) ................................................................... Total ........................................................................................................
Dated: January 21, 2005. Betsey Dunaway, Acting Reports Clearance Officer, Office of the Chief Science Officer, Centers for Disease Control and Prevention. [FR Doc. 05–1589 Filed 1–27–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services
[Document Identifier: CMS–R–50 and CMS– 10054]
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s function; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Medical Records Review under Inpatient PPS and Supporting Regulations in 42 CFR, Sections 412.40–412.52; Form No: CMS–R–50 (OMB# 0938–0359); Use: The Quality Improvement Organizations (QIOs) are authorized to conduct medical review activities under the Prospective Payment System (PPS). In order to conduct these review activities, CMS depends upon hospitals to make available specific records regarding care
provided to Medicare beneficiaries. The Clinical Data Abstraction Centers (CDACs) obtain copies of medical records from which they abstract data to analyze patterns of care and outcomes for heart failure/myocardial infarction, pneumonia, diabetes and surgical infection; Frequency: When records are reviewed; Affected Public: Business or other for-profit, Not-for-profit institutions, Federal Government, and State, Local or Tribal Government; Number of Respondents: 6,100; Total Annual Responses: 397,500; Total Annual Hours: 11,925. 2. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Recognition of Payment for New Technology Services for Ambulatory Payment Classifications (APCs) Under the Outpatient Prospective Payment System and Supporting Regulations in 42 CFR, Sections 413.65 and 419.42; Form Number: CMS–10054 (OMB# 0938– 0860); Use: Information is necessary to determine eligibility of medical devices for establishment of additional device categories for payment under transitional pass-through payment
15:43 Jan 27, 2005